Indonesia Compulsory License Move A Sharp Warning On Cost Pressures In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Indonesia decree for compulsory license of HIV/AIDS and hepatitis drugs shows prospect of further actions by some countries in Asia could gather speed.